Lichterfeld, Mathias <br/><br/>
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Jan 2012 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-7884 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e3182373b77  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>CD4-Positive T-Lymphocytes--cytology<br/>Cell Proliferation<br/>Double-Blind Method<br/>Female<br/>HIV Envelope Protein gp120--immunology<br/>HIV Infections--drug therapy<br/>HIV-1--immunology<br/>Humans<br/>Male<br/>Middle Aged<br/>Vaccines, Subunit--immunology<br/>Young Adult<br/>nef Gene Products, Human Immunodeficiency Virus--immunology<br/>tat Gene Products, Human Immunodeficiency Virus--immunology